- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Probiotic Supplementation may Prevent Recurrent Urinary Tract Infections
A recent study published in the Clinical Infectious Diseases explored the alternative strategies such as the effectiveness of probiotic supplementation to combat recurrent urinary tract infections (UTIs).
This double-blind, placebo-controlled trial enrolled a total of 174 premenopausal women with a history of recurrent UTIs. The participants were divided into four groups and administered either oral probiotics, vaginal probiotics, a combination of both or placebos over a span of four months.
The results revealed that at the four-month mark, the incidence of UTIs in participants who received vaginal probiotics or the combination of oral and vaginal probiotics was significantly lower when compared to those in the placebo group. Also, the mean number of symptomatic UTI recurrences was significantly reduced in these groups which indicate the benefits of probiotic supplementation.
The time to the first symptomatic UTI was significantly prolonged in the groups receiving vaginal probiotics or the combination regimen, underscoring the potential for these interventions to provide long-term protection against recurrent UTIs. The probiotic supplements were well tolerated by participants and no serious adverse events were observed. This suggests that probiotic supplementation could offer a safe and effective alternative or adjunctive therapy for individuals prone to recurrent UTIs.
The study highlighted the importance of these findings in the context of growing antibiotic resistance which emphasize the benefits of probiotics as a nonantibiotic strategy in preventing recurrent UTIs. Probiotics offers promise for reducing the burden of UTIs while minimizing the risk of antibiotic resistance by promoting a healthy balance of bacteria in the urinary and vaginal tracts. Further research on the role of probiotics in urinary tract health may inform clinical guidelines for the prevention and management of recurrent UTIs.
Reference:
Gupta, V., Mastromarino, P., & Garg, R. (2023). Effectiveness of Prophylactic Oral and/or Vaginal Probiotic Supplementation in the Prevention of Recurrent Urinary Tract Infections: A Randomized, Double-Blind, Placebo-Controlled Trial. In Clinical Infectious Diseases. Oxford University Press (OUP). https://doi.org/10.1093/cid/ciad766
Neuroscience Masters graduate
Jacinthlyn Sylvia, a Neuroscience Master's graduate from Chennai has worked extensively in deciphering the neurobiology of cognition and motor control in aging. She also has spread-out exposure to Neurosurgery from her Bachelor’s. She is currently involved in active Neuro-Oncology research. She is an upcoming neuroscientist with a fiery passion for writing. Her news cover at Medical Dialogues feature recent discoveries and updates from the healthcare and biomedical research fields. She can be reached at editorial@medicaldialogues.in
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751